Under the umbrella of the German Biobank Node (GBN), 11 biobanks and two IT development centers are funded by the Federal Ministry of Education and Research (BMBF) to work together in the German Biobank Alliance (GBA). Their common aim is to make existing biomaterials hosted by different biobanks nationally and internationally available for biomedical research. This position article reflects and summarizes contributions and comments made during a GBA workshop, on the cooperation between academic biobanks and pharmaceutical and diagnostics companies that took place in Leipzig on the 21st of June 2018. It documents key points agreed on by all participating biobanks during the workshop thereby addressing several of the challenges identified. Although there are various possibilities for cooperation between academic biobanks and industry, this position article focuses exclusively on projects where academic biobanks give access to their biosamples and related data to industry partners. In doing so it considers the general conditions/framework and procedures in the German biobanking environment and raises ethical, legal, and procedural issues to be addressed when initiating such collaborations. It intends to furnish a basis for further activities to foster cooperation with industry and to push an overarching national coordination process. The final aim is to develop GBN-recommendations. Of course, many hospitals already have clear regulations on collaboration(s) with industry partners. These naturally take precedence for the GBA biobanks. However, where interest exists, GBN/GBA recommendations could help to induce changes to existing local policies nonetheless.

中文翻译：

---

德国生物库联盟关于学术生物库与行业合作伙伴之间合作的立场声明。

在德国生物库节点（GBN）的保护下，联邦教育与研究部（BMBF）资助了11家生物库和两个IT开发中心，共同在德国生物库联盟（GBA）中开展工作。他们的共同目标是使国内外不同生物库托管的现有生物材料可用于生物医学研究。本立场文章反映并总结了2018年6月21日在莱比锡举行的GBA研讨会上关于学术生物库与制药和诊断公司之间合作的贡献和意见。该文档记录了所有参与的生物库在评估期间所达成的关键点。研讨会，从而解决了所确定的一些挑战。尽管学术生物库与产业界之间存在各种合作的可能性，本位置文章专门针对学术生物库向行业合作伙伴提供其生物样本和相关数据的项目。在此过程中，它考虑了德国生物银行环境中的一般条件/框架和程序，并提出了在启动此类合作时要解决的道德，法律和程序问题。它打算为进一步的活动提供基础，以促进与工业界的合作并推动总体的国家协调进程。最终目的是制定GBN建议。当然，许多医院已经对与行业合作伙伴的合作制定了明确的法规。对于GBA生物库，这些自然优先。但是，在有兴趣的地方，GBN / GBA建议仍然可以帮助引发对现有本地政策的更改。